Ocugen Inc
Change company Symbol lookup
Select an option...
OCGN Ocugen Inc
APPH AppHarvest Inc
MACQW MCAP Acquisition Corp *W EXP 02/18/2026
QCOM Qualcomm Inc
NEXNF NEXE Innovations Inc
GRCL Gracell Biotechnologies Inc
NRG NRG Energy Inc
VNO Vornado Realty Trust
COTY Coty Inc
RPHM Reneo Pharmaceuticals Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19. The Company's technology pipeline includes: COVID-19 Vaccine (0.5), Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases. COVID-19 Vaccine is developing, manufacturing and commercializing COVAXIN for the prevention of COVID-19 in humans in the Ocugen Covaxin Territory. COVAXIN is a whole-virion inactivated COVID-19 vaccine candidate and is formulated with the inactivated SARS-CoV-2 virus. The Modifier Gene Therapy platform is designed for retinal diseases, including retinitis pigmentosa (RP), leber congenital amaurosis (LCA) and dry age-related macular degeneration (AMD). It is developing OCU200, a novel biologic product candidate to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet AMD. OCU400, its first product candidate being developed with its modifier gene therapy platform.

Closing Price
$7.53
Day's Change
-0.08 (-1.05%)
Bid
--
Ask
--
B/A Size
--
Day's High
8.08
Day's Low
7.52
Volume
(Average)
Volume:
15,139,122

10-day average volume:
16,015,501
15,139,122
  • Prev Close
    7.61
  • Today's Open
    7.53
  • Day's Range
    7.52-8.08
  • Avg Vol (10-day)
    16.0M
  • Last (time)
    4:00p ET 09/24/21
  • Last (size)
    10
  • 52-Wk Range
    0.2501 - 18.77
    LowHigh
  • (11/02/20 - 02/08/21)
    2,910.80%
  • 245.0%
  • Market Cap
    1.5B
  • Shares Outstanding
    198.8M
  • -0.27
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 4.5
  • 27.15
  • (% of float 09/15/21)
    27.20

Latest News

September 24, 2021
10:50 pm ET
PR Newswire
5:13 pm ET
MarketWatch
September 23, 2021
5:13 pm ET
MarketWatch
4:08 pm ET
Globe Newswire
September 22, 2021
5:13 pm ET
MarketWatch
September 21, 2021
5:14 pm ET
MarketWatch
September 20, 2021
5:13 pm ET
MarketWatch
September 17, 2021
5:13 pm ET
MarketWatch
4:52 pm ET
Globe Newswire
September 16, 2021
5:14 pm ET
MarketWatch
September 15, 2021
5:13 pm ET
MarketWatch
September 14, 2021
5:13 pm ET
MarketWatch
1:23 pm ET
PR Newswire
September 13, 2021
5:13 pm ET
MarketWatch
September 10, 2021
10:50 pm ET
BusinessWire
5:13 pm ET
MarketWatch
September 09, 2021
5:13 pm ET
MarketWatch
September 07, 2021
5:22 pm ET
Globe Newswire
August 20, 2021
4:34 pm ET
Globe Newswire
August 17, 2021
12:26 pm ET
Accesswire
11:49 am ET
Newsfile
11:00 am ET
Accesswire
9:43 am ET
Newsfile
9:36 am ET
Globe Newswire
8:00 am ET
Globe Newswire
August 16, 2021
6:02 pm ET
Newsfile
4:25 pm ET
Newsfile
1:20 pm ET
Accesswire
11:44 am ET
Newsfile
10:31 am ET
Accesswire
August 15, 2021
12:38 pm ET
Newsfile
12:13 pm ET
Accesswire
10:10 am ET
Newsfile
August 13, 2021
8:00 pm ET
BusinessWire
7:21 pm ET
Newsfile
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.